PPARGC1A and ovarian endometrioid adenocarcinoma: To test the relationship between PGC1α and chemoresistance in patient-derived cancer cells, we collected and isolated the cellular portion of 14 ascites from patients with serous, clear cell, and endometrioid ovarian cancer at advanced stage III – IV (Table 1).